SCYNEXIS
1D
1W
1M
3M
YTD
1Y
5Y
ALL
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell SCYNEXIS and other ETFs, options, and stocks.About SCYX
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J.
CEODavid Angulo Gonzalez
CEODavid Angulo Gonzalez
Employees28
Employees28
HeadquartersJersey City, New Jersey
HeadquartersJersey City, New Jersey
Founded1999
Founded1999
Employees28
Employees28
SCYX Key Statistics
Market cap27.90M
Market cap27.90M
Price-Earnings ratio-1.21
Price-Earnings ratio-1.21
Dividend yield—
Dividend yield—
Average volume146.35K
Average volume146.35K
High today$0.766
High today$0.766
Low today$0.67
Low today$0.67
Open price$0.68
Open price$0.68
Volume112.79K
Volume112.79K
52 Week high$2.29
52 Week high$2.29
52 Week low$0.66
52 Week low$0.66
People also own
Based on the portfolios of people who own SCYX. This list is generated using Robinhood data, and it’s not a recommendation.